Spots Global Cancer Trial Database for personalized medicine
Every month we try and update this database with for personalized medicine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma | NCT03219047 | Recurrent Mantl... Refractory Mant... | Best Practice Ibrutinib Patient Derived... Personalized Me... | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma | NCT04965454 | Hepatocellular ... | Fluorine-18 flu... | 18 Years - | Queen's Medical Center | |
| Risk-Based Breast Screening in Young Women | NCT05675085 | Breast Neoplasm... | Personalized sc... | 45 Years - 45 Years | Istituto Oncologico Veneto IRCCS | |
| Matching Patients With Hematologic Malignancy to Adequate Clinical Trials | NCT02758080 | Hematologic Mal... | Matching on the... Matching on the... | 18 Years - | Seoul National University Hospital | |
| Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies | NCT05598788 | Blood Concentra... | Measurement of ... | 18 Years - | Rennes University Hospital | |
| Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma | NCT04965454 | Hepatocellular ... | Fluorine-18 flu... | 18 Years - | Queen's Medical Center | |
| N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy | NCT02142036 | Metastatic Canc... | EMA-approved AT... | 18 Years - | Oslo University Hospital | |
| Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics | NCT06295029 | Acute Myeloid L... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | ||
| In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies | NCT04873427 | Prostate Cancer Genetic Predisp... | clonal heteroge... | - | Clinica Luganese Moncucco | |
| Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor. | NCT03943771 | Kidney Neoplasm... Carcinoma, Rena... | Anxiety, renal ... | 18 Years - | University Hospital, Bordeaux | |
| Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer) | NCT03053297 | Carcinoma, Non-... | Patient Reporte... | 18 Years - | AstraZeneca | |
| Personalized Exercise Oncology | NCT04328038 | Cancer Health Behavior | Survey | 18 Years - | University Hospital Heidelberg | |
| Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma | NCT00617656 | Non Small Cell ... BRCA1 Mutation | Cisplatin, Doce... Gemcitabine, Ci... Docetaxel, Cisp... Docetaxel | 18 Years - | Spanish Lung Cancer Group | |
| Matching Patients With Hematologic Malignancy to Adequate Clinical Trials | NCT02758080 | Hematologic Mal... | Matching on the... Matching on the... | 18 Years - | Seoul National University Hospital | |
| Gastric Cancer Risk Factors Associated With EU and CELAC Populations | NCT03957031 | Cancer, Gastric | 18 Years - 90 Years | Fundación para la Investigación del Hospital Clínico de Valencia | ||
| N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy | NCT02142036 | Metastatic Canc... | EMA-approved AT... | 18 Years - | Oslo University Hospital | |
| Predictive Genetic Risk Assessment Trial | NCT00782366 | Colon Cancer Lung Cancer Atrial Fibrilla... Diabetes Type 2 Obesity Breast Cancer Graves Disease Osteoarthritis Celiac Disease Myocardial Infa... Prostate Cancer | SNP analysis | 18 Years - 65 Years | Mayo Clinic | |
| A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial | NCT04786600 | Metastatic Colo... | Signatera ctDNA... pre-specified s... | 18 Years - 99 Years | University of Florida | |
| Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor. | NCT03943771 | Kidney Neoplasm... Carcinoma, Rena... | Anxiety, renal ... | 18 Years - | University Hospital, Bordeaux | |
| Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics | NCT06295029 | Acute Myeloid L... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | ||
| IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins | NCT01939847 | Metastatic Brea... | Treatment sugge... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer | NCT02008994 | Metastatic Brea... | Genomic and Pro... | 18 Years - | Sanford Health | |
| Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer | NCT05830279 | Nausea With Vom... Depression, Rea... Cancer Pain | Pharmacogenetic... Drug-Drug inter... | 18 Years - | Lawson Health Research Institute | |
| Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples | NCT04246710 | Pancreas Cancer | 18 Years - 80 Years | Catholic University of the Sacred Heart | ||
| Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population | NCT04019808 | Gastric Cancer | 18 Years - 90 Years | Fundación para la Investigación del Hospital Clínico de Valencia | ||
| Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies | NCT04470947 | Advanced Lympho... Refractory Lymp... Refractory Leuk... Refractory Acut... Refractory T-Ce... | Next generation... Comprehensive g... | 18 Years - | Medical University of Vienna | |
| Evaluation of Oral Potentially Malignant Disorders (OPMDs) With STRATICYTE™ | NCT05853783 | Mouth Diseases | STRATICYTE™ Tes... | 18 Years - | Proteocyte Diagnostics Inc. | |
| Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts | NCT02752893 | Breast Cancer | 18 Years - | Dartmouth-Hitchcock Medical Center | ||
| Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma | NCT05248750 | Pancreas Cancer | 18 Years - 80 Years | Catholic University of the Sacred Heart | ||
| Peptide-based Immunization for Colon- and and Pancreas-carcinoma | NCT03871790 | Colon Neoplasm Colon Adenocarc... Colon Cancer Colo-rectal Can... Rectal Cancer Rectal Neoplasm... Rectal Adenocar... Rectal Tumors Pancreatic Canc... Pancreas Cancer Pancreatic Neop... Pancreatic Aden... | 18 Years - | CENTOGENE GmbH Rostock | ||
| Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts | NCT02752893 | Breast Cancer | 18 Years - | Dartmouth-Hitchcock Medical Center | ||
| Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population | NCT04019808 | Gastric Cancer | 18 Years - 90 Years | Fundación para la Investigación del Hospital Clínico de Valencia | ||
| Matching Patients With Hematologic Malignancy to Adequate Clinical Trials | NCT02758080 | Hematologic Mal... | Matching on the... Matching on the... | 18 Years - | Seoul National University Hospital | |
| Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics | NCT06295029 | Acute Myeloid L... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | ||
| Predictive Genetic Risk Assessment Trial | NCT00782366 | Colon Cancer Lung Cancer Atrial Fibrilla... Diabetes Type 2 Obesity Breast Cancer Graves Disease Osteoarthritis Celiac Disease Myocardial Infa... Prostate Cancer | SNP analysis | 18 Years - 65 Years | Mayo Clinic | |
| Personalized Exercise Oncology | NCT04328038 | Cancer Health Behavior | Survey | 18 Years - | University Hospital Heidelberg | |
| Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment | NCT05695638 | Solid Tumor, Un... Haematological ... | 18 Years - | Aalborg University Hospital | ||
| Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma | NCT05248750 | Pancreas Cancer | 18 Years - 80 Years | Catholic University of the Sacred Heart | ||
| A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors | NCT05576077 | Breast Cancer Colorectal Canc... Uveal Melanoma Cutaneous Melan... Non-Small Cell ... Head and Neck S... | TBio-4101 Pembrolizumab | 18 Years - 70 Years | Turnstone Biologics, Corp. | |
| Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care | NCT04212390 | MDS (Myelodyspl... | 18 Years - 100 Years | Fondazione Italiana Sindromi Mielodisplastiche-ETS | ||
| Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells | NCT04105582 | Breast Cancer Triple Negative... | Neo-antigen pul... | 18 Years - 75 Years | Universidad Nacional de Colombia | |
| Advanced GC Multi-omic Characterization in EU and CELAC Populations | NCT04015466 | Gastric Cancer | 18 Years - 90 Years | Fundación para la Investigación del Hospital Clínico de Valencia | ||
| Personalized Exercise Oncology | NCT04328038 | Cancer Health Behavior | Survey | 18 Years - | University Hospital Heidelberg | |
| Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies | NCT04470947 | Advanced Lympho... Refractory Lymp... Refractory Leuk... Refractory Acut... Refractory T-Ce... | Next generation... Comprehensive g... | 18 Years - | Medical University of Vienna | |
| Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery- Rein 3D Anxiety | NCT06035211 | Tumoral Kidney | 3D model pré-op... | 18 Years - | University Hospital, Bordeaux | |
| Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment | NCT05695638 | Solid Tumor, Un... Haematological ... | 18 Years - | Aalborg University Hospital | ||
| Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma | NCT03056599 | Soft Tissue Sar... | Multiple drug m... CIVO device | 18 Years - | Presage Biosciences | |
| Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment | NCT04622462 | Oral Neoplasm | Standard of Car... STRATICYTE Asse... | 15 Years - 90 Years | Proteocyte Diagnostics Inc. | |
| Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents | NCT01831505 | Lymphoma | Multiple drug m... | 18 Years - | Presage Biosciences | |
| Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment | NCT05695638 | Solid Tumor, Un... Haematological ... | 18 Years - | Aalborg University Hospital | ||
| Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response | NCT03154710 | Lymphoma, T-Cel... Lymphoma, Large... Lymphoma, Hodgk... | MOOVCARE | 18 Years - | Weprom | |
| Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma | NCT00617656 | Non Small Cell ... BRCA1 Mutation | Cisplatin, Doce... Gemcitabine, Ci... Docetaxel, Cisp... Docetaxel | 18 Years - | Spanish Lung Cancer Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
